Seth Robey

437 total citations
10 papers, 323 citations indexed

About

Seth Robey is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Seth Robey has authored 10 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Seth Robey's work include Cancer Immunotherapy and Biomarkers (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Ion channel regulation and function (2 papers). Seth Robey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Ion channel regulation and function (2 papers). Seth Robey collaborates with scholars based in United States, Switzerland and France. Seth Robey's co-authors include Robert S. Kass, Kevin J. Sampson, Veena R. Iyer, Michael S. Bohnen, Cécile Terrenoire, Gary Peng, Jeremiah D. Osteen, H. Peter Larsson, René Barro-Soria and Lokesh Jain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Physiological Reviews.

In The Last Decade

Seth Robey

8 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seth Robey United States	6	186	167	81	77	53	10	323
Oliver Lomas United Kingdom	9	190 1.0×	63 0.4×	82 1.0×	15 0.2×	28 0.5×	22	331
Weijia Luo United States	9	278 1.5×	52 0.3×	58 0.7×	22 0.3×	29 0.5×	18	379
Łukasz Kozera Poland	11	215 1.2×	78 0.5×	16 0.2×	19 0.2×	15 0.3×	21	425
P Borri Italy	10	151 0.8×	70 0.4×	21 0.3×	33 0.4×	93 1.8×	25	382
Aurélie Thollet France	11	265 1.4×	288 1.7×	79 1.0×	10 0.1×	8 0.2×	22	469
Ian Winburn United Kingdom	10	203 1.1×	31 0.2×	93 1.1×	11 0.1×	15 0.3×	20	349
Tatsuya Nishikawa Japan	10	173 0.9×	55 0.3×	95 1.2×	6 0.1×	13 0.2×	37	315
Jacqueline J. Tao United States	4	123 0.7×	89 0.5×	48 0.6×	9 0.1×	11 0.2×	10	332
Nerea Lago‐Baameiro Spain	9	193 1.0×	87 0.5×	31 0.4×	7 0.1×	49 0.9×	14	290
Kathryn A. Stackhouse United States	10	101 0.5×	64 0.4×	50 0.6×	4 0.1×	38 0.7×	28	294

Countries citing papers authored by Seth Robey

Since Specialization

Citations

This map shows the geographic impact of Seth Robey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Robey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Robey more than expected).

Fields of papers citing papers by Seth Robey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Robey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Robey. The network helps show where Seth Robey may publish in the future.

Co-authorship network of co-authors of Seth Robey

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Robey. A scholar is included among the top collaborators of Seth Robey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Robey. Seth Robey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Duffull, Stephen B., Julie A. Stone, & Seth Robey. (2024). Mechanistic Model of Alzheimer’s Disease Progression: Linking Amyloid and Tau Pathologies. Alzheimer s & Dementia. 20(S6).

Ruiz-Garcı́a, Ana, Paul Baverel, Dean Bottino, et al.. (2023). A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. Journal of Pharmacokinetics and Pharmacodynamics. 50(3). 147–172. 28 indexed citations

Plock, Nele, Akshita Chawla, Seth Robey, et al.. (2022). Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach. EBioMedicine. 84. 104264–104264. 9 indexed citations

Plock, Nele, Akshita Chawla, Seth Robey, et al.. (2021). 1010. Cross-Species Translation of Correlates of Protection for COVID-19 Vaccine Candidates Using Quantitative Tools. Open Forum Infectious Diseases. 8(Supplement_1). S595–S596.

Stone, Julie A., Ellen Snyder, Leslie Lipka, et al.. (2019). Immunogenicity of pembrolizumab in patients with advanced tumors. Journal for ImmunoTherapy of Cancer. 7(1). 212–212. 44 indexed citations

Atkins, Michael B., F. Stephen Hodi, John A. Thompson, et al.. (2018). Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study. Clinical Cancer Research. 24(8). 1805–1815. 48 indexed citations

Schwartz, Lawrence H., Seth Robey, David C. Turner, et al.. (2018). Correlation of survival outcomes with progression heterogeneity in patients (pts) treated with pembrolizumab (pembro).. Journal of Clinical Oncology. 36(15_suppl). 3017–3017. 1 indexed citations

Bohnen, Michael S., Gary Peng, Seth Robey, et al.. (2016). Molecular Pathophysiology of Congenital Long QT Syndrome. Physiological Reviews. 97(1). 89–134. 116 indexed citations

Robey, Seth & Frank David. (2016). Drug launch curves in the modern era. Nature Reviews Drug Discovery. 16(1). 13–14. 5 indexed citations

10.

Osteen, Jeremiah D., René Barro-Soria, Seth Robey, et al.. (2012). Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels. Proceedings of the National Academy of Sciences. 109(18). 7103–7108. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact